Gold Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
34,292
+837
+3% +$80.2K 0.92% 42
2025
Q4
$3.21M Sell
33,455
-348
-1% -$33.8K 1.03% 37
2025
Q3
$3.22M Buy
33,803
+921
+3% +$84.7K 1.08% 36
2025
Q2
$2.91M Buy
32,882
+531
+2% +$45K 1.09% 39
2025
Q1
$2.91M Buy
32,351
+1,351
+4% +$121K 1.23% 31
2024
Q4
$2.48M Buy
31,000
+441
+1% +$38.2K 1.04% 36
2024
Q3
$2.75M Sell
30,559
-15
-0% -$1.26K 1.15% 31
2024
Q2
$2.41M Buy
30,574
+229
+0.8% +$18.8K 1.02% 38
2024
Q1
$2.64M Buy
30,345
+1,580
+5% +$135K 1.07% 36
2023
Q4
$2.37M Buy
+28,765
New +$2.19M 1.01% 36

Other funds holding MDT

Gold Investment Management's MDT Position: Q1 2026 in Review

Gold Investment Management increased its Medtronic (MDT) stake by 2.5% in Q1 2026, buying an estimated $80.2K and bringing the position to 34,292 shares worth $2.97M. The position accounts for 0.92% of the portfolio, ranked #42.

Gold Investment Management first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.22M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Gold Investment Management held 34,292 shares of Medtronic worth $2.97M as of Q1 2026.
  • Gold Investment Management bought 837 Medtronic shares in Q1 2026, an estimated $80.2K.
  • Medtronic made up 0.92% of Gold Investment Management's portfolio in Q1 2026, its #42 holding.
  • Gold Investment Management first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Gold Investment Management's Medtronic position peaked at $3.22M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Gold Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.